Claims
- 1. A 3,4-di-O,N-protected-4-amino-2,4,6-trideoxy-2-fluoro-L-mannopyranosyl halide represented by the following formula ##STR42## wherein Y' is acetyl or benzoyl group, Y" is trifluoroacetyl group and X is bromine or iodine atom.
- 2. A process of preparing a 3,4-di-O,N-protected-4-amino-2,4,6-trideoxy-2-fluoro-L-mannopyranosyl halide of the formula (III) ##STR43## wherein Y' is acetyl or benzoyl group, Y" is trifluoroacetyl group and X is bromine or iodine atom, which comprises consecutive steps of reacting the 3-hydroxyl group of methyl 4-O-benzyl-2,6-dideoxy-2-fluoro-.alpha.-L-talopyranoside (Compound (1)) of the formula ##STR44## wherein Bn denotes benzyl group, with tert-butylchlorodimethylsilane to produce methyl 4-O-benzyl-3-O-tert-butyldimethylsilyl-2,6-dideoxy-2-fluoro-.alpha.-L-talopyranoside (Compound (2)) of the formula ##STR45## wherein Bn is as defined above and TBS denotes tert-butyldimethylsilyl group, eliminating the benzyl group at the 4-position of compound (2) therefrom by catalytic reduction with hydrogen in the presence of a palladium catalyst, to produce methyl 3-O-tert-butyldimethylsilyl-2,6-dideoxy-2-fluoro-.alpha.-L-talopyranoside (Compound (3) of the formula ##STR46## wherein TBS is as defined above, sulfonating the 4-hydroxyl group of Compound (3) with trifluoromethanesulfonic anhydride to produce methyl 3-O-tert-butyldimethylsilyl-2,6-dideoxy-2-fluoro-4-O-trifluoromethylsulfonyl-.alpha.-L-talopyranoside (Compound (4)) of the formula ##STR47## wherein TBS is as defined above, as the 4-O-sulfonylation product, reacting this Compound (4) with lithium azide in anhydrous N,N-dimethylformamide, to make the configuration of the 4-position inverted and simultaneously effect the azidation at the 4-position and thus to afford methyl 4-azido-3-O-tert-butyldimethylsilyl-2,4,6-trideoxy-2-fluoro-.alpha.-L-mannopyranoside (Compound (5)) of the formula ##STR48## wherein TBS is as defined above, as the 4-azidated product, reducing the 4-azido group of Compound (5) into 4-amino group by catalytic reduction with hydrogen in the presence of Raney-nickel catalyst, to produce methyl 4-amino-3-O-tert-butyldimethylsilyl-2,4,6-trideoxy-2-fluoro-.alpha.-L-mannopyranoside (Compound (6)) of the formula ##STR49## wherein TBS is as defined above, acylating the 4-amino group of Compound (6) with trifluoroacetic anhydride in pyridine, to form methyl 3-O-tert-butyldimethylsilyl-2,4,6-trideoxy-2-fluoro-4-(trifluoroacetylamino)-.alpha.-L-mannopyranoside (Compound (7)) of the formula ##STR50## wherein TBS is as defined above, as the 4-N-protected product, treating this Compound (7) with a mixture of acetic anhydride, acetic acid and sulfuric acid at room temperature, to effect simultaneously the removal of the 3-O-tert-butyldimethylsilyl group, demethylation and di-O-acetylation reactions, and thus to afford 1,3-di-O-acetyl-2,4,6-trideoxy-2-fluoro-4-(trifluoroacetylamino)-L-mannopyranose (Compound (8)) of the formula ##STR51## wherein Ac denotes acetyl group, or treating the aforesaid Compound (7) with a mixture of benzoic anhydride, benzoic acid and sulfuric acid, to obtain 1,3-di-O-benzoyl-2,4,6-trideoxy-2-fluoro-4-(trifluoroacetylamino)-L-mannopyranose Compound (8'), and then brominating Compound (8) or Compound (8') in a solution of hydrogen bromide in acetic acid, or iodinating Compound (8) or Compound (8') with iodotrimethylsilane in anhydrous toluene to give 3-O-acetyl or benzoyl-2,4,6-trideoxy-2-fluoro-4-(trifluoroacetylamino)-.alpha.-L-mannopyranosyl bromide or iodide of the formula (III) above or represented by the following formula (III') ##STR52## wherein Y' is acetyl or benzoyl group and X is bromine or iodine atom.
- 3. Methyl 4-amino-3-O-tert-butyldimethylsilyl-2,4,6-trideoxy-2-fluoro-.alpha.-L-mannopyranoside (Compound (6)) of the formula ##STR53## wherein TBS denotes tert-butyldimethylsilyl group.
Priority Claims (1)
Number |
Date |
Country |
Kind |
7-179621 |
Jun 1995 |
JPX |
|
Parent Case Info
This is a division of application Ser. No. 08/981,255 filed Dec. 22, 1997, now U.S. Pat. No. 5,958,889; which is a 371 of PCT/JP96/01697 filed Jun. 19, 1996.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5034517 |
Umezawa et al. |
Jul 1991 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
981255 |
|
|